Page last updated: 2024-11-02

pamidronate and Histiocytosis, Langerhans-Cell

pamidronate has been researched along with Histiocytosis, Langerhans-Cell in 9 studies

Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.

Research Excerpts

ExcerptRelevanceReference
"Although patients diagnosed as Langerhans cell histiocytosis (LCH) with bone lesion initially respond well to treatment, some may experience relapse or refractory disease."1.42Bisphosphonate Therapy for Refractory Langerhans Cell Histiocytosis: A Case Report. ( Buaboonnam, J; Narkbunnam, N; Sanpakit, K; Takpradit, C; Vathana, N, 2015)
"Several studies have suggested that Langerhans cell histiocytosis (LCH) is responsive to treatment with bisphosphonates (BPs)."1.37Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan. ( Anan, T; Hama, A; Imamura, T; Kamizono, J; Kanegane, H; Kinoshita, A; Kudo, K; Miyaji, R; Morimoto, A; Nagatoshi, Y; Nakadate, H; Nakagawa, S; Sato, T; Shioda, Y; Tauchi, H; Yabe, M; Yasui, M, 2011)
"The reasons for bisphosphonate treatment were multiple myeloma in 12 patients, breast cancer with bone metastasis in four patients and histiocytosis X in one patient."1.33Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. ( Baumann, A; Czerny, C; Eisenmenger, G; Ewers, R; Hoffmann, M; Moser, D; Pietschmann, P; Wutzl, A, 2006)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takpradit, C1
Vathana, N1
Narkbunnam, N1
Sanpakit, K1
Buaboonnam, J1
Morimoto, A1
Shioda, Y1
Imamura, T1
Kanegane, H1
Sato, T1
Kudo, K1
Nakagawa, S1
Nakadate, H1
Tauchi, H1
Hama, A1
Yasui, M1
Nagatoshi, Y1
Kinoshita, A1
Miyaji, R1
Anan, T1
Yabe, M1
Kamizono, J1
Alloh Amichia, YC1
Le Bars, P1
Giumelli, B1
Soueidan, A1
Wutzl, A1
Eisenmenger, G1
Hoffmann, M1
Czerny, C1
Moser, D1
Pietschmann, P1
Ewers, R1
Baumann, A1
Farran, RP1
Zaretski, E1
Egeler, RM2
Arzoo, K1
Sadeghi, S1
Pullarkat, V1
Brown, RE1
Lockridge, L1
Papac, RJ1
Perazella, MA1

Other Studies

9 other studies available for pamidronate and Histiocytosis, Langerhans-Cell

ArticleYear
Bisphosphonate Therapy for Refractory Langerhans Cell Histiocytosis: A Case Report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2015, Volume: 98, Issue:11

    Topics: Antineoplastic Agents; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Neopl

2015
Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan.
    Pediatric blood & cancer, 2011, Volume: 56, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Diphosphonates; Disease-Free Survival; Drug Evaluation; Drug-Re

2011
[Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case].
    Odonto-stomatologie tropicale = Tropical dental journal, 2010, Volume: 33, Issue:132

    Topics: Adult; Alendronate; Bone Density Conservation Agents; Denture Design; Denture, Partial, Fixed; Dentu

2010
Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:15-16

    Topics: Adult; Aged; Biopsy; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Fol

2006
Treatment of Langerhans cell histiocytosis with pamidronate.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Diphosphonates; Histiocytosis, Langerhans-Cell; Humans; Male;

2001
Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis.
    The New England journal of medicine, 2001, Jul-19, Volume: 345, Issue:3

    Topics: Adult; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Osteolysis; Pain; Pamidronate

2001
More on pamidronate in Langerhans'-cell histiocytosis.
    The New England journal of medicine, 2001, Nov-15, Volume: 345, Issue:20

    Topics: Adolescent; Anti-Inflammatory Agents; Diphosphonates; Histiocytosis, Langerhans-Cell; Humans; Male;

2001
More on pamidronate in Langerhans'-cell histiocytosis.
    The New England journal of medicine, 2001, Nov-15, Volume: 345, Issue:20

    Topics: Anti-Inflammatory Agents; Diphosphonates; Histiocytosis, Langerhans-Cell; Humans; Mevalonic Acid; Os

2001
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:1

    Topics: Anti-Inflammatory Agents; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Kidney Tub

2002